PAPER Park SS, Schulz EM, Lee D
SEARCH RESULTS
330907 RESULTS
PAPER Rekas A, Jankova L, Thorn DC, Cappai R, Carver JA
Monitoring the prevention of amyloid fibril formation by alpha-crystallin. Temperature dependence and the nature of the aggregating species.
FEBS J. 2007 Dec;274(24):6290-304. PubMed: 18005258PAPER Abe K, Kobayashi N, Sode K, Ikebukuro K
Peptide ligand screening of alpha-synuclein aggregation modulators by in silico panning.
BMC Bioinformatics. 2007;8:451. PubMed: 18005454PAPER Preusser M, Kitzwoegerer M, Budka H, Brugger S
Bilateral striopallidodentate calcification (Fahr's syndrome) and multiple system atrophy in a patient with longstanding hypoparathyroidism.
Neuropathology. 2007 Oct;27(5):453-6. PubMed: 18018479PAPER Asanuma M, Miyazaki I, Diaz-Corrales FJ, Miyoshi K, Ogawa N, Murata M
Preventing effects of a novel anti-parkinsonian agent zonisamide on dopamine quinone formation.
Neurosci Res. 2008 Jan;60(1):106-13. PubMed: 18022268PAPER Postuma RB, Gagnon JF, Montplaisir J
Autonomic dysfunction in RBD--what can it teach us about disease progression?
Sleep Med. 2008 Jul;9(5):473-4. PubMed: 18024175PAPER Zakharov SD, Hulleman JD, Dutseva EA, Antonenko YN, Rochet JC, Cramer WA
Helical alpha-synuclein forms highly conductive ion channels.
Biochemistry. 2007 Dec 18;46(50):14369-79. PubMed: 18031063PAPER Sasaki S, Shirata A, Yamane K, Iwata M
Involvement of spinal motor neurons in parkin-positive autosomal recessive juvenile parkinsonism.
Neuropathology. 2008 Feb;28(1):74-80. PubMed: 18031467PAPER Nafia I, Re DB, Masmejean F, Melon C, Kachidian P, Kerkerian-Le Goff L, Nieoullon A, Had-Aissouni L
Preferential vulnerability of mesencephalic dopamine neurons to glutamate transporter dysfunction.
J Neurochem. 2008 Apr;105(2):484-96. PubMed: 18042178PAPER Kalaitzakis ME, Graeber MB, Gentleman SM, Pearce RK
The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease: a critical analysis of alpha-synuclein staging.
Neuropathol Appl Neurobiol. 2008 Jun;34(3):284-95. PubMed: 18053026PAPER Alvarez-Fischer D, Henze C, Strenzke C, Westrich J, Ferger B, Höglinger GU, Oertel WH, Hartmann A
Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and alpha-synuclein-deleted mice.
Exp Neurol. 2008 Mar;210(1):182-93. PubMed: 18053987PAPER Mash DC, Adi N, Duque L, Pablo J, Kumar M, Ervin FR
Alpha synuclein protein levels are increased in serum from recently abstinent cocaine abusers.
Drug Alcohol Depend. 2008 Apr 1;94(1-3):246-50. PubMed: 18055133PAPER Horvath MC, Kovacs GG, Kovari V, Majtenyi K, Hurd YL, Keller E
Heroin abuse is characterized by discrete mesolimbic dopamine and opioid abnormalities and exaggerated nuclear receptor-related 1 transcriptional decline with age.
J Neurosci. 2007 Dec 5;27(49):13371-5. PubMed: 18057194PAPER Parker WD, Parks JK, Swerdlow RH
Complex I deficiency in Parkinson's disease frontal cortex.
Brain Res. 2008 Jan 16;1189:215-8. PubMed: 18061150PAPER Ahmad MF, Raman B, Ramakrishna T, Rao Ch
Effect of phosphorylation on alpha B-crystallin: differences in stability, subunit exchange and chaperone activity of homo and mixed oligomers of alpha B-crystallin and its phosphorylation-mimicking mutant.
J Mol Biol. 2008 Jan 25;375(4):1040-51. PubMed: 18061612Current Filters
No filters selected